Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 2013

View Archived Issues

Investigators optogenetically delay seizures in animal models

Mouse model of congenital indifference to pain created

Copeptin is a marker of future stroke risk after transient ischemic attack

Diuretic and natriuretic effect of LCZ-696 in patients with hypertension

Researchers discover novel genetic biomarker for several human diseases

Expression of three genes predicts tolerance in renal transplant recipients

Millennium presents preclinical results for novel antibody-drug conjugate MLN-0264

Bio-Path opens enrollment in sixth cohort of phase I liposomal GRB2 trial

Second Genome and Janssen enter microbiome drug discovery agreement

Novavax develops novel coronavirus vaccine candidate

Oculus Innovative Sciences enters into agreement with Ruthigen

Esperion Therapeutics reports results from phase II study of ETC-1002

DMC recommends continuation of phase II ICT-107 trial

Eisai launches Belviq for chronic weight management

Researchers at Glenmark Pharmaceuticals patent new MPGES-1 inhibitors

Xention prepares new potassium channel blockers

Racotumomab, which improves lung cancer survival rate, soon to be available in Argentina

Gilead Sciences' receives priority review for sofosbuvir NDA

First compound from Eisai and Quintiles' anticancer collaboration demonstrates proof of concept

AstraZeneca signs definitive agreement to acquire Pearl Therapeutics

FDA approves Fluzone Quadrivalent influenza vaccine

EMA approves RoActemra for polyarticular juvenile idiopathic arthritis

Merck & Co. discloses novel GPR119 receptor agonists

Cephalon divulges new protein kinase inhibitors

Scientists at Astellas Pharma present novel DAAO inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...